Eculizumab (Anti-Complement C5)

製品コード：A2538 Batch: A253801

Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.

製品説明

CAS No.	219685-50-4
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype	Human IgG1
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping	Shipped under low temperature conditions
Purity	99%
Protein concentration	11.6mg/ml
Endotoxin Level	＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。